Catalyst Oncology

Research management organization Pharmatech is changing its name and focus to better reflect the company’s presence in the fast-growing oncology research market. As of January 1, the Denver-based company is doing business as Pharmatech Oncology, a subsidiary of Pharmatech. Company executives hope this name change will distinguish the company’s core services from other contract research and site management organizations (CROs and SMOs). “Over the years, we have focused ourselves on a variety o

The rest is here: 
Pharmatech Retools to Focus on Oncology